EXAMINE THIS REPORT ON MBL77

Not all individuals with CLL require therapy. Inspite of all recent advances, the iwCLL continue to recommends watchful observation for people with asymptomatic ailment.86 This recommendation is predicated on at the least two randomized trials comparing observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR